Summarised studies Safety profile Topical and parenteral GHK-Cu have been extensively studied for local tolerability and have a well-characterised dermatological safety profile from decades of cosmetic use
3000 x g , 4 C, 10 min), and concentrated 100-fold by ultrafiltration (Amicon, 100 kDa)
The compound is referenced across a wide spectrum of preclinical models, with most literature focusing on three thematic areas: Skin biology: Studies on dermal fibroblast behaviour, collagen and elastin synthesis pathways, and extracellular matrix remodelling Gene expression modulation: Research examining the compounds reported activity across thousands of genes in genome-wide expression studies Antioxidant & copper transport: Models exploring its role as a physiological copper carrier and free radical interaction The 50mg and 100mg vial formats make GHK-Cu particularly suitable for extended research protocols where higher peptide volumes are required compared with the typical 510mg formats used for other research compounds
BPC-157 is a synthetic peptide studied for tissue repair, gut health and inflammation research
BPC-157 BIOPRIME Medical uses pharmaceutical-grade compounded BPC-157 sourced from trusted, licensed compounding pharmacies as part of personalized treatment plans
That depends on your situation
